David Clapper - Minerva Surgical CEO Pres
| UTRSDelisted Stock | USD 0.26 0.00 0.00% |
Insider
David Clapper is CEO Pres of Minerva Surgical
| Age | 71 |
| Phone | 855 646 7874 |
| Web | https://minervasurgical.com |
Minerva Surgical Management Efficiency
The company has return on total asset (ROA) of (0.2735) % which means that it has lost $0.2735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6008) %, meaning that it created substantial loss on money invested by shareholders. Minerva Surgical's management efficiency ratios could be used to measure how well Minerva Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Minerva Surgical currently holds 39.69 M in liabilities with Debt to Equity (D/E) ratio of 1.3, which is about average as compared to similar companies. Minerva Surgical has a current ratio of 2.35, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Minerva Surgical until it has trouble settling it off, either with new capital or with free cash flow. So, Minerva Surgical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Minerva Surgical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Minerva to invest in growth at high rates of return. When we think about Minerva Surgical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 9 records | INSIDER Age | ||
| Tejinder Virk | Akanda Corp | 42 | |
| Robert Dudley | Transcode Therapeutics | 73 | |
| BCom BAcc | Akanda Corp | 44 | |
| Thomas Flow | Akanda Corp | 46 | |
| BComm BCom | Akanda Corp | 68 | |
| Qiyong Liu | Transcode Therapeutics | 60 | |
| Gerald Proehl | Dermata Therapeutics | 65 | |
| David Hale | Dermata Therapeutics | 75 | |
| Anna Moore | Transcode Therapeutics | 62 | |
Management Performance
| Return On Equity | -1.6 | ||||
| Return On Asset | -0.27 |
Minerva Surgical Leadership Team
Elected by the shareholders, the Minerva Surgical's board of directors comprises two types of representatives: Minerva Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Minerva. The board's role is to monitor Minerva Surgical's management team and ensure that shareholders' interests are well served. Minerva Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Minerva Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joanne Long, VP Controller | ||
| Dominique Filloux, Chief Officer | ||
| Wendy Bowman, VP HR | ||
| Evgueni MD, VP Affairs | ||
| David Clapper, CEO Pres | ||
| Thomas Pendlebury, VP Marketing | ||
| Joel MBA, Chief Officer |
Minerva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Minerva Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.6 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 42.81 M | ||||
| Shares Outstanding | 8.88 M | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 89.86 % | ||||
| Number Of Shares Shorted | 37.42 K | ||||
| Price To Book | 0.51 X |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Minerva Pink Sheet
If you are still planning to invest in Minerva Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Minerva Surgical's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |